Article 11 Aug 2022 The Seventh Circuit Asks, "What's Wrong With Having Lots Of Patents?" United States IP
Article 13 Jul 2022 In The Courtroom: The Importance Of Educating The Judge During Patent & Life Sciences Cases (Video) United States IP
Article 28 Feb 2022 "Negative" Patent Claim Limitations—May They Be Adequately Described By Omission? United States IP
Article 27 Jan 2022 Skinny Labels May Not Be Dead: Delaware District Court Distinguishes GSK, Dismisses Induced Infringement Claim United States Healthcare
Article 22 Nov 2021 Juno V. Kite: Written Description And Claiming Antibodies And Chimeric Antigen Receptors—Lessons For Patent Prosecutors United States Healthcare
Article 13 Oct 2021 In The Orphan Drug Approval Race, Winner Takes All? Ramifications Of Catalyst Pharms. V. Becerra United States Healthcare
Article 23 Aug 2021 GSK v. Teva: Federal Circuit Issues New Opinion Analyzing Induced Infringement United States Healthcare
Article 30 Jul 2021 President Biden's Executive Order On Competition Signals Potential Changes Affecting Patents In The Healthcare Sector United States Healthcare
Article 28 Jul 2021 Induced Infringement Of Method Of Treatment Claims: Looking To The Label And Beyond United States IP
Article 27 Jul 2021 "Advancing Education On Biosimilars": Game Changer Or More Of The Same? United States Healthcare